Search Results - "Nagaraj, A.B"

The use of novel PP2A activators in combination with PARP inhibitor for the treatment of high-grade serous ovarian cancer by Armstrong, A.J, Joseph, P, Nagaraj, A.B, Nagel, C.I, Nakayama, J, Waggoner, S.E, Zanotti, K.M, DiFeo, A, Narla, G

Get full text

The wnt/β-catenin-specific inhibitor, ICG-001, proves effective for the treatment of high-grade serous ovarian cancer in murine models through the targeting of cancer initiating cells by Connor, R.S, Nagaraj, A.B, Joseph, P, Mantilla, S, Kovalenko, O, Nagel, C.I, Nakayama, J, Waggoner, S.E, Zanotti, K.M, Singh, S, DiFeo, A

Get full text

Small molecule activators of protein phosphatase 2A for the treatment of endometrial cancer by Joseph, P, Nagaraj, A.B, Armstrong, A, Resnick, K.E, Zanotti, K.M, Waggoner, S.E, Narla, G, DiFeo, A

Get full text

The use of novel PP2A activators in combination withPARP inhibitor for the treatment of high-grade serous ovarian cancer by Armstrong, A.J., Joseph, P., Nagaraj, A.B., Nagel, C.I., Nakayama, J., Waggoner, S.E., Zanotti, K.M., DiFeo, A., Narla, G.

Get full text